Date published: 2026-5-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

cyclin D2 Inhibitors

Cyclin D2 inhibitors belong to a chemical class of compounds designed to target and inhibit the activity of cyclin D2, a member of the cyclin protein family. Cyclins are critical regulators of the cell cycle, specifically controlling the progression of cells through various phases of division. Cyclin D2, in particular, plays a pivotal role in the G1 phase of the cell cycle, where it forms complexes with cyclin-dependent kinases (CDKs) to promote the transition from G1 to S phase. The inhibition of cyclin D2 by these compounds is intended to disrupt the formation of cyclin D2-CDK complexes, thereby arresting the cell cycle at the G1 phase and stopping cells from progressing into the S phase. By targeting cyclin D2, these inhibitors seek to modulate cell division and proliferation, which can have implications for various biological processes, including tissue growth and repair. Research into cyclin D2 inhibitors offers insights into the molecular mechanisms underlying cell cycle regulation and their impact on cellular behaviors.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

PD 0332991 is a CDK4/6 inhibitor that can indirectly affect Cyclin D2 by inhibiting its complex formation with CDK4/6, leading to cell cycle arrest.

Ribociclib

1211441-98-3sc-507367
10 mg
$450.00
(0)

Ribociclib is a CDK4/6 inhibitor similar to Palbociclib, interfering with Cyclin D2-CDK4/6 complexes and halting cell cycle progression in certain cancers.

Abemaciclib

1231929-97-7sc-507342
10 mg
$110.00
(0)

Abemaciclib, another CDK4/6 inhibitor, hinders Cyclin D2-CDK4/6 interactions, causing cell cycle arrest and suppressing cancer cell growth.